Skip to main content

Cigna Value Stock - Dividend - Research Selection

Cigna

ISIN: US1255231003 , WKN: A2PA9L

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. It operates through Global Health Care, Global Supplemental Benefits, Group Disability and Life, and Other Operations segments. The Global Health Care segment offers medical, dental, behavioral health, vision, and prescription drug benefit plans, as well as health advocacy programs, and other products and services to insured and self-insured customers. This segment also provides Medicare Advantage and Medicare Part D plans to seniors, and Medicaid plans. The Global Supplemental Benefits segment offers supplemental health, life, and accident insurance products. The Group Disability and Life segment provides group long-term and short-term disability, group life, accident, and specialty insurance products and related services. The Other Operations segment offers corporate-owned life insurance products that are permanent insurance contracts sold to corporations to provide coverage; and run-off settlement annuity contracts. The company distributes its products and services through insurance brokers and insurance consultants; and directly to employers, unions and other groups, or individuals, as well as through direct response television and the Internet. Cigna Corporation was founded in 1792 and is headquartered in Bloomfield, Connecticut.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Cigna Group (CI) Valuation Check After Portfolio Changes And FTC Settlement

2026-02-26
The Cigna Group (CI) is back in focus after recent portfolio moves around Shields Health Solutions, the sale of its Medicare business, and a broad Federal Trade Commission settlement tied to pharmacy benefits operations. See our latest analysis for Cigna Group. Those portfolio moves and regulatory resolutions have arrived during a mixed stretch for investors, with a 30 day share price return of 5.31% contrasting with a 1 year total shareholder return decline of 4.17%. This hints at improving...

Acadia Healthcare Q4 Earnings Beat Estimates on Rising Admissions

2026-02-25
ACHC tops Q4 estimates as admissions and patient days rise, lifting revenues, but profit plunges 89% year over year.

These 4 charts show the scale of Novo Nordisk's woes

2026-02-25
Despite being first to launch a GLP-1 drug for weight loss, Novo's market share has eroded, and the company now only captures about 40% of the market.

Novo Nordisk to slash GLP-1 list prices by up to 50% in U.S. to cut costs for insured patients

2026-02-24
The cuts aim to make the drugs more accessible to insured patients, particularly people with high-deductible health plans or coinsurance benefit designs.

Truist Raises Cigna (CI) Price Target to $350, Sees Clearer Growth Outlook after Q4

2026-02-24
The Cigna Group (NYSE:CI) is included among the 13 Best Strong Buy Dividend Stocks to Invest in. On February 17, Truist raised its price recommendation on The Cigna Group (NYSE:CI) to $350 from $320. The firm reiterated a Buy rating on the stock. The analyst updated the firm’s model following the company’s Q4 results and its […]

Cigna Group stock outperforms competitors on strong trading day

2026-02-23
Cigna Group stock outperforms competitors on strong trading day

Fancy clothes, mealtime alarms and Disney princess gigs: How GLP-1s are changing people's lives in unexpected ways

2026-02-23
GLP-1 drugs for weight loss are growing in popularity in the U.S. and across the world. Here's what some users say about their experiences with the medicines.

Select Medical Q4 Earnings Miss Estimates on Increasing Expenses

2026-02-20
SEM posts a Q4 EPS miss as rising expenses and margin pressure weigh on results despite revenue growth and strength in key segments.

Cigna Group stock underperforms Friday when compared to competitors

2026-02-20
Cigna Group stock underperforms Friday when compared to competitors

Cigna Group stock underperforms Thursday when compared to competitors

2026-02-19
Cigna Group stock underperforms Thursday when compared to competitors